PCG
LJPC

Private Capital Group’s La Jolla Pharmaceutical Company LJPC Stock Holding History

Private Capital Group’s Portfolio LJPC Stock Details LJPC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-36
Closed -$1K – 2665
2019
Q2 		$1K Buy
+36
New +$271 ﹤0.01% 2148
2018
Q4 		– Sell
-36
Closed – – 2475
2018
Q3 		$0 Hold
36
– – ﹤0.01% 2404
2018
Q2 		$1K Hold
36
– – ﹤0.01% 2095
2018
Q1 		$1K Buy
+36
New +$1.16K ﹤0.01% 2098

Other funds holding LJPC

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VMI
VHCP Management III New York $504M AUM 683.12% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Private Capital Group's LJPC Position: Q3 2019 in Review

Private Capital Group sold out of La Jolla Pharmaceutical Company (LJPC) in Q3 2019, closing a stake of 36 shares — an estimated $1K sold.

Private Capital Group first reported a position in LJPC in Q1 2018 and held it in 4 quarters. The position peaked at $1K in Q2 2019. 75 funds tracked by Wall St. Rank hold LJPC as of Q3 2019.

  • Private Capital Group reported no remaining La Jolla Pharmaceutical Company position as of Q3 2019 after selling out during the quarter.
  • Private Capital Group sold 36 La Jolla Pharmaceutical Company shares in Q3 2019, an estimated $1K.
  • Private Capital Group first reported a position in La Jolla Pharmaceutical Company in Q1 2018 and held it in 4 quarters.
  • Private Capital Group's La Jolla Pharmaceutical Company position peaked at $1K in Q2 2019.
  • 75 funds tracked by Wall St. Rank held La Jolla Pharmaceutical Company as of Q3 2019.

Based on Private Capital Group's 13F filing for Q3 2019, filed 13 Nov 2019.